News

Filter

Current filters:

Licensing

1 to 9 of 1787 results

Norgine partners with Navidea for Lymphoseek marketing in Europe

05-03-2015

Netherlands-headquartered independent drugmaker Norgine says that its affiliate, SpePharm AG, has entered…

BiotechnologyEuropeLicensingLymphoseekNavidea BiopharmaceuticalsNorgineOncology

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

04-03-2015

Clinical-stage biopharma company arGEN-X has exercised its option to exclusively license preclinical…

arGEN-XBelgiumBiotechnologyLicensingOncology

Bavarian Nordic set to earn $975 million in Prostvac deal

Bavarian Nordic set to earn $975 million in Prostvac deal

04-03-2015

Danish biotech firm Bavarian Nordic has granted US pharma major Bristol-Myers Squibb an exclusive option…

Bavarian NordicBiotechnologyBristol-Myers SquibbLicensingOncologyProstvacVaccinesYervoy

Lilly licenses pomaglumetad methionil to Denovo as potential schizophrenia therapy

Lilly licenses pomaglumetad methionil to Denovo as potential schizophrenia therapy

03-03-2015

US drug major Eli Lilly has licensed late-stage neuroscience drug pomaglumetad methionil (mGlu2/3 receptor…

Eli LillyLicensingNeurologicalPharmaceuticalpomaglumetad methionilUSA

Blueprint Medicines in up to $265 million deal with Alexion

03-03-2015

Privately-held Blueprint Medicines has entered a strategic collaboration with USA-based Alexion Pharmaceuticals…

Alexion PharmaceuticalsBlueprint MedicinesLicensingPharmaceuticalRare diseases

Islet Sciences gains certain rights for Phase II SGLT2 inhibitor remogliflozin

Islet Sciences gains certain rights for Phase II SGLT2 inhibitor remogliflozin

03-03-2015

US biotech firm Islet Sciences has entered into a license agreement with Brighthaven Ventures (BHV) for…

BiotechnologyBrighthaven VenturesDiabetesIslet SciencesLicensingNephrology and Hepatologyremogliflozin

Endo to divest its American Medical Systems men's and prostate businesses to Boston Scientific

Endo to divest its American Medical Systems men's and prostate businesses to Boston Scientific

03-03-2015

Ireland-headquartered Endo International has entered into a definitive agreement with Boston Scientific…

EndoLicensingMen's HealthPharmaceuticalUSA

Amgen licenses AMG 714 to start-up Celimmune

Amgen licenses AMG 714 to start-up Celimmune

02-03-2015

USA-based biotech company Amgen has licensed a Phase II-stage anti-IL-15 monoclonal antibody, AMG 714,…

AmgenBiotechnologyGastro-intestinalsImmunologicalsLicensingUSA

1 to 9 of 1787 results

COMPANY SPOTLIGHT

Menarini

Back to top